Jump to main content
Jump to site search
SCHEDULED MAINTENANCE Close the message box

Maintenance work is planned for Monday 16 August 2021 from 07:00 to 23:59 (BST).

Website performance may be temporarily affected and you may not be able to access some PDFs or images. If this does happen, refreshing your web browser should resolve the issue. We apologise for any inconvenience this might cause and thank you for your patience.


All chapters

Chapter 15

CRISPR Highlights and Transition of Cas9 into a Genome Editing Tool

CRISPR–cas systems provide microbial immunity to invasive genetic elements in many bacteria and most investigated archea. This chapter highlights important advances following the discovery of CRISPR–cas, its function in immunity and the biochemical characterisation of a subset of immune-effector components, which together target and cleave foreign genomes in a sequence-specific manner. These advances encouraged transplantation of engineered CRISPRS–cas components into human cells to induce sequence-targeted double-strand breaks followed by cell-mediated repair, thereby effectively repurposing CRISPR effectors into efficient genome-editing tools exploiting the different eukaryotic repair pathways. The challenges of genome-wide specific targeting versus potentially harmful off-target activity and efforts to improve target specificity using protein engineering are discussed. The chapter concludes with a brief summary of current ongoing human trials involving CRISPR–cas and the challenges facing clinical development of the technology.

Publication details


Print publication date
12 Mar 2018
Copyright year
2018
Print ISBN
978-1-78262-992-4
PDF eISBN
978-1-78801-292-8
ePub eISBN
978-1-78801-428-1
From the book series:
Chemical Biology